[Semaglutide, once weekly GLP-1 receptor agonist (Ozempic®)].
Year: 2019
Type: article
Source: PubMed
Author: A J Scheen
Institution: Centre Hospitalier Universitaire de Liège
Language: French
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2994626215
